Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02351063 · ClinicalTrials.gov registry record · NA
HF Assessment With BNP in the Home: Part II
A NA study, sponsored by Alere San Diego.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02351063: Clinical Trial NA study, sponsored by Alere San Diego.
NCT02351063 is a NA study that was terminated before completion, run by Alere San Diego. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02351063, a NA study, was terminated before completion, sponsored by Alere San Diego.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
HABIT-II is a feasibility study aimed at home monitoring of patients with heart failure. B-type natriuretic peptide (BNP) has strong correlations to the severity of heart failure. Lower BNP levels are closely associated with better clinical outcomes. The goal of HABIT-II is to demonstrate that the results of daily patient self-testing of BNP at home will provide sufficient information to guide physicians to modify therapy and lower BNP levels over time.
Primary Outcome
After a short lead-in period, an algorithm (similar in concept to a moving average) will be applied to the BNP data resulting in a BNP-based parameter. The primary endpoint of the study is a significant lowering of BNP across the population, such that values for the population are reduced to levels below a predetermined threshold and kept below the threshold for the duration of subsequent testing and observation.
Interventions
- DRUG Changes of heart failure medications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-07 |
| Phase | NA |
Why NCT02351063 stopped before completion
NCT02351063 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Changes of heart failure medications is the first listed.
NCT02351063 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02351063 about?
NCT02351063 is a clinical study titled "HF Assessment With BNP in the Home: Part II". HABIT-II is a feasibility study aimed at home monitoring of patients with heart failure. B-type natriuretic peptide (BNP) has strong correlations to the severity of heart failure. Lower BNP levels are closely associated with better clinical outcomes. The goal of HABIT-II is to demonstrate that the r...
What is the current status of trial NCT02351063?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2014-04. Estimated completion is 2014-07.
What interventions are being tested in trial NCT02351063?
The interventions under investigation include: Changes of heart failure medications (DRUG).
Who is sponsoring clinical trial NCT02351063?
This trial is sponsored by Alere San Diego, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02351063's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia